Kisqali 600 MG daily dose UU 63S
Ended Awarded Last action
- Contract number
- SPE2DR26FM1DY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,374
Award facts
- Contract value 100% obligated
- $11,374.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,374.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Kisqali 600 mg daily dose tablets in a quantity of 63 units. The contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance will be conducted at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 15, 2026. Kisqali is a hormone receptor-positive breast cancer treatment, reflecting the Defense Health Agency's ongoing pharmaceutical procurement needs to support military beneficiary care.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical supply vendor with extensive experience fulfilling military healthcare requirements. The company's DLA contract vehicle enables it to supply a comprehensive portfolio of pharmaceutical products, brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. This delivery order represents a routine transaction within the broader pharmaceutical prime vendor relationship and demonstrates the company's continued role as a primary source for specialty pharmaceutical commodities within the military health system.
Quick answers
Who was awarded contract SPE2DR26FM1DY?
SPE2DR26FM1DY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FM1DY worth?
The government has obligated $11,374 on SPE2DR26FM1DY.
Is contract SPE2DR26FM1DY an order under another contract?
Yes. SPE2DR26FM1DY is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM1DY competed?
The extent of competition for SPE2DR26FM1DY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award